Literature DB >> 9693943

Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall--evidence that plaque cholesterol may be derived from post-prandial lipoproteins.

S D Proctor1, J C Mamo.   

Abstract

Plaque cholesterol is thought to be derived exclusively from low-density lipoproteins that have become trapped and modified in the subendothelial space of arterial vessels. However, in this study we provide the first visual evidence that demonstrates that (a) remnants of post-prandial lipoproteins rapidly penetrate arterial tissue; (b) efflux is not complete; and (c) focal accumulation of chylomicron remnants occurs within the subendothelial space. The arterial retention of chylomicron remnants is consistent with atherogenesis being in part a post-prandial phenomenon.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693943     DOI: 10.1046/j.1365-2362.1998.00317.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  30 in total

Review 1.  Postprandial lipemia and cardiovascular disease.

Authors:  Dianne Hyson; John C Rutledge; Lars Berglund
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

2.  Robert Graves Memorial Lecture. Diabetes and atherosclerosis--a gut review.

Authors:  G H Tomkin
Journal:  Ir J Med Sci       Date:  2002 Apr-Jun       Impact factor: 1.568

3.  Reproducibility of postprandial lipemia tests and validity of an abbreviated 4-hour test.

Authors:  Edward P Weiss; David A Fields; Bettina Mittendorfer; M A Dorien Haverkort; Samuel Klein
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

4.  Regulating intestinal function to reduce atherogenic lipoproteins.

Authors:  M Mahmood Hussain; Tung Ming Leung; Liye Zhou; Sarah Abu-Merhi
Journal:  Clin Lipidol       Date:  2013-08-01

5.  Fatty acids increase glucose uptake and metabolism in C2C12 myoblasts stably transfected with human lipoprotein lipase.

Authors:  Warren H Capell; Isabel R Schlaepfer; Pamela Wolfe; Peter A Watson; Daniel H Bessesen; Michael J Pagliassotti; Robert H Eckel
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-13       Impact factor: 4.310

Review 6.  Postprandial hypertriglyceridemia and cardiovascular disease: current and future therapies.

Authors:  D C Chan; J Pang; G Romic; G F Watts
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

7.  Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels.

Authors:  M T Pedrini; M Kranebitter; A Niederwanger; S Kaser; J Engl; P Debbage; L A Huber; J R Patsch
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

8.  Postprandial Monocyte Activation in Individuals With Metabolic Syndrome.

Authors:  Ilvira M Khan; Yashashwi Pokharel; Razvan T Dadu; Dorothy E Lewis; Ron C Hoogeveen; Huaizhu Wu; Christie M Ballantyne
Journal:  J Clin Endocrinol Metab       Date:  2016-08-30       Impact factor: 5.958

9.  Increased postprandial triglyceride-rich lipoprotein levels in elderly survivors of myocardial infarction.

Authors:  Samira Lekhal; Trond Børvik; Arne Nordøy; John-Bjarne Hansen
Journal:  Lipids       Date:  2008-04-04       Impact factor: 1.880

Review 10.  Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk.

Authors:  Jila Kaberi Otarod; Ira J Goldberg
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.